These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14781471)

  • 1. [Mechanism of the therapeutic action of sulfone derivatives in lepromatous leprosy].
    de SOUZA PR; de LIMA MS
    Rev Bras Leprol; 1950 Jun; 18(2):59-68. PubMed ID: 14781471
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of lepromatous leprosy with 4:4'-diaminodiphenyl sulfone in oil; findings in 100 cases treated for one year.
    MOLESWORTH BD; NARAYANASWAMI PS
    Int J Lepr; 1949; 17(3):197-210, 5 pl. PubMed ID: 15399691
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diamino-diphenyl-sulfone, dihydrostreptomycin and p-aminosalicylic acid in the treatment of lepromatous leprosy].
    GONZALEZ OCHOA A; MARTINEZ BAEZ M; LAVALLE AGUILAR P; CASTRO ESTRADA S
    Bol Oficina Sanit Panam; 1952 Oct; 33(4):306-29. PubMed ID: 12977879
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation studies in lepromatous leprosy. 4. 4, Butoxy-4'dimethylaminodiphenyl thiourea (DPT), amodiaquin, and 4-4'diaminodiphenyl sulfone (DDS) 2.5 mgm, and 4 mgm. per kg. of body weight.
    DOULL JA; RODRIGUEZ JN; TOLENTINO JG; FERNANDEZ JV; GUINTO RS; RIVERA JN; MABALAY MC
    Int J Lepr; 1961; 29():291-317. PubMed ID: 13887566
    [No Abstract]   [Full Text] [Related]  

  • 5. [The very rapidly favorable action of sulfamethopyrazine on a reactional outbreak of lepromatous leprosy].
    DEGOS R; LORTAT-JACOB E; REY M
    Bull Soc Fr Dermatol Syphiligr; 1961; 68():865-8. PubMed ID: 13884882
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the treatment of 15 cases of lepromatous leprosy with 4-4'-diaminodiphenylsulfone].
    LANGUILLON J
    Bull Soc Pathol Exot Filiales; 1951; 44(5-6):322-9. PubMed ID: 13066934
    [No Abstract]   [Full Text] [Related]  

  • 7. ICONOGRAPHIA DERMATOLOGICA. 11. SUBCUTANEOUS "BORDERLINE NODULES" IN LEPROMATOUS LEPROSY.
    OGAWA J; KANETSUNA F; TODA E; NISHIURA M
    Hifuka Kiyo; 1963 Jan; 58():1-2. PubMed ID: 14045185
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic evaluation of bacterial conversion in lepromatous leprosy: a comparative study with sulphone and hydnocarpus oil.
    MUKHERJEE N; GHOSH S; GHOSAL P; KUNDU S
    J Indian Med Assoc; 1961 May; 36():396-8. PubMed ID: 13773654
    [No Abstract]   [Full Text] [Related]  

  • 9. A trial of antigen marianum as an adjunct of D.D.S. in the treatment of lepromatous leprosy.
    BECKETT DW
    Lepr Rev; 1958 Oct; 29(4):209-14. PubMed ID: 13589102
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of diaminodiphenylsulfone and thiosemicarbazone in the treatment of lepromatous leprosy; clinical and bacteriological evaluation in sixty hospitalized patients.
    SAGHER F; BRAND N
    Int J Lepr; 1953; 21(2):161-7. PubMed ID: 13096167
    [No Abstract]   [Full Text] [Related]  

  • 11. LEPROMATOUS HANSEN'S DISEASE.
    ROSENTHAL AL; RATHMELL TK
    J Med Soc N J; 1964 May; 61():198-200. PubMed ID: 14145915
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of lepromatous leprosy by a combination of DDS and sarsaparilla (Smilax ornata).
    ROLLIER R
    Int J Lepr; 1959; 27():328-40. PubMed ID: 14438529
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bacteriological action of 1-(p-[N,N-dimethylaminolphenyl)-3-(p-n-butoxyphenyl)-2-thiorea on leprosy of the lepromatous type and on leprosy of the sulfone-resistant dimorphic type].
    MONTESTRUC E; BENOIST J
    Bull Soc Pathol Exot Filiales; 1960; 53():13-6. PubMed ID: 13848669
    [No Abstract]   [Full Text] [Related]  

  • 14. Vadrine combined with sulphone in the treatment of lepromatous leprosy.
    JOPLING WH; RIDLEY DS
    Lepr Rev; 1961 Jul; 32():188-90. PubMed ID: 13790666
    [No Abstract]   [Full Text] [Related]  

  • 15. [The 4:4 '-diamino diphenyl sulfone in the treatment of lepromatous leprosy].
    DUARTE LG; DE MELLO PH
    Rev Bras Leprol; 1953 Sep; 21(3):207-20. PubMed ID: 13167563
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of lepromatous leprosy with neovadrine and vadrine in combination with DDS.
    ALLAN JA
    Lepr Rev; 1961 Jul; 32():191-3. PubMed ID: 13682476
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action of sulfones in leprosy. IX. Mechanism of action of thymol derivatives of sulfone (silver or non-silver salts) administered orally].
    FLOCH H; GELARD A
    Publ Inst Pasteur Guyane Fr Inini; 1955 Mar; 16(357):1-11. PubMed ID: 13249662
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of leprosy of a lepromatous and tuberculoid form with neural lesions; evolution under the effect of sulfone therapy].
    ALAJOUANINE T; CASTAIGNE P; BLATRIX C
    Rev Neurol (Paris); 1951 Jan; 84(1):65-7. PubMed ID: 14845363
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation studies in lepromatous leprosy; third series: nicotinamide, and BCG vaccination as supplements to diaminodiphenyl sulfone (DDS).
    DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV
    Int J Lepr; 1958; 26(3):219-35. PubMed ID: 13640759
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.